Science & technology | A new outbreak of disease

Monkeypox is not covid mk2, but it needs to be nipped in the bud

The illness can be dangerous for children, pregnant women and the immunocompromised

Monkeypox virus particles, illustration. Monkeypox virus particles are composed of a DNA (deoxyribonucleic acid) genome surrounded by a protein coat and lipid envelope. This virus, which is found near rainforests in Central and West Africa causes disease in humans and monkeys, although its natural hosts are rodents. It is capable of human to human transmission. In humans it causes fever, swollen glands and a rash of fluid-filled blisters. It is fatal in 10 per cent of cases.

Since britain reported a case of monkeypox on May 7th, more than 300 further instances have been noted across the world. The disease, which is usually confined to Africa, is now present in at least 17 countries in Europe and five other non-African ones (see map).

This article appeared in the Science & technology section of the print edition under the headline “The spread of monkeypox”

China’s slowdown

From the May 28th 2022 edition

Discover stories from this section and more in the list of contents

Explore the edition

More from Science & technology

A person blowing about a pattern in the shape of a brain

Can you breathe stress away?

Scientists are only beginning to understand the links between the breath and the mind

The Economist’s science and technology internship

We invite applications for the 2025 Richard Casement internship


A man sits inside a pixelated pink brain while examining a clipboard, with colored squares falling from the brain

A better understanding of Huntington’s disease brings hope

Previous research seems to have misinterpreted what is going on


Is obesity a disease?

It wasn’t. But it is now

Volunteers with Down’s syndrome could help find Alzheimer’s drugs

Those with the syndrome have more of a protein implicated in dementia

Should you start lifting weights?

You’ll stay healthier for longer if you’re strong